Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

1.

Dexamethasone for the prevention of postoperative atrial fibrillation.

van Osch D, Dieleman JM, van Dijk D, Jacob KA, Kluin J, Doevendans PA, Nathoe HM; DExamethasone for Cardiac Surgery (DECS) study group.

Int J Cardiol. 2015 Jan 8;182C:431-437. doi: 10.1016/j.ijcard.2014.12.094. [Epub ahead of print]

PMID:
25596472
2.

Exploring homogeneity of correlation structures of gene expression datasets within and between etiological disease categories.

Jong VL, Novianti PW, Roes KC, Eijkemans MJ.

Stat Appl Genet Mol Biol. 2014 Dec;13(6):717-32. doi: 10.1515/sagmb-2014-0003.

PMID:
25503674
3.

Reporting of covariate selection and balance assessment in propensity score analysis is suboptimal: a systematic review.

Ali MS, Groenwold RH, Belitser SV, Pestman WR, Hoes AW, Roes KC, Boer Ad, Klungel OH.

J Clin Epidemiol. 2015 Feb;68(2):112-21. doi: 10.1016/j.jclinepi.2014.08.011. Epub 2014 Nov 26.

PMID:
25433444
4.

Performance of prior event rate ratio adjustment method in pharmacoepidemiology: a simulation study.

Uddin MJ, Groenwold RH, van Staa TP, de Boer A, Belitser SV, Hoes AW, Roes KC, Klungel OH.

Pharmacoepidemiol Drug Saf. 2014 Nov 20. doi: 10.1002/pds.3724. [Epub ahead of print]

PMID:
25410590
5.

Effects of dexamethasone on cognitive decline after cardiac surgery: a randomized clinical trial.

Ottens TH, Dieleman JM, Sauër AM, Peelen LM, Nierich AP, de Groot WJ, Nathoe HM, Buijsrogge MP, Kalkman CJ, van Dijk D; DExamethasone for Cardiac Surgery (DECS) Study Group.

Anesthesiology. 2014 Sep;121(3):492-500. doi: 10.1097/ALN.0000000000000336.

PMID:
25225745
6.

Quantitative falsification of instrumental variables assumption using balance measures.

Ali MS, Uddin MJ, Groenwold RH, Pestman WR, Belitser SV, Hoes AW, de Boer A, Roes KC, Klungel OH.

Epidemiology. 2014 Sep;25(5):770-2. doi: 10.1097/EDE.0000000000000152. No abstract available.

PMID:
25076152
7.

Sample size calculations in pediatric clinical trials conducted in an ICU: a systematic review.

Nikolakopoulos S, Roes KC, van der Lee JH, van der Tweel I.

Trials. 2014 Jul 8;15:274. doi: 10.1186/1745-6215-15-274.

8.

Dexamethasone for the prevention of postpericardiotomy syndrome: A DExamethasone for Cardiac Surgery substudy.

Bunge JJ, van Osch D, Dieleman JM, Jacob KA, Kluin J, van Dijk D, Nathoe HM; Dexamethasone for Cardiac Surgery (DECS) Study Group.

Am Heart J. 2014 Jul;168(1):126-31.e1. doi: 10.1016/j.ahj.2014.03.017. Epub 2014 Apr 5.

PMID:
24952869
9.

Evaluation of gene expression classification studies: factors associated with classification performance.

Novianti PW, Roes KC, Eijkemans MJ.

PLoS One. 2014 Apr 25;9(4):e96063. doi: 10.1371/journal.pone.0096063. eCollection 2014.

10.

Exploring interaction effects in small samples increases rates of false-positive and false-negative findings: results from a systematic review and simulation study.

Schmidt AF, Groenwold RH, Knol MJ, Hoes AW, Nielen M, Roes KC, de Boer A, Klungel OH.

J Clin Epidemiol. 2014 Jul;67(7):821-9. doi: 10.1016/j.jclinepi.2014.02.008. Epub 2014 Apr 24.

PMID:
24768005
11.

Effects of recruitment strategies and demographic factors on inclusion in a large scale vaccination trial in adults 65 years and older.

Smorenburg AJ, Oosterman BJ, Grobbee DE, Bonten MJ, Roes KC.

Vaccine. 2014 May 23;32(25):2989-94. doi: 10.1016/j.vaccine.2014.03.081. Epub 2014 Apr 5.

PMID:
24713367
12.

Improving clinical trial efficiency by biomarker-guided patient selection.

Boessen R, Heerspink HJ, De Zeeuw D, Grobbee DE, Groenwold RH, Roes KC.

Trials. 2014 Apr 2;15:103. doi: 10.1186/1745-6215-15-103.

13.

A compilation of research working groups on drug utilisation across Europe.

Sabaté M, Pacheco JF, Ballarín E, Ferrer P, Petri H, Hasford J, Schoonen MW, Rottenkolber M, Fortuny J, Laporte JR, Ibáñez L; PROTECT Work Package 2.

BMC Res Notes. 2014 Mar 13;7:143. doi: 10.1186/1756-0500-7-143.

14.

Justification of exclusion criteria was underreported in a review of cardiovascular trials.

Schmidt AF, Groenwold RH, van Delden JJ, van der Does Y, Klungel OH, Roes KC, Hoes AW, van der Graaf R.

J Clin Epidemiol. 2014 Jun;67(6):635-44. doi: 10.1016/j.jclinepi.2013.12.005. Epub 2014 Mar 5. Review.

PMID:
24613498
15.

The effect of renal denervation added to standard pharmacologic treatment versus standard pharmacologic treatment alone in patients with resistant hypertension: rationale and design of the SYMPATHY trial.

Vink EE, de Beus E, de Jager RL, Voskuil M, Spiering W, Vonken EJ, de Wit GA, Roes KC, Bots ML, Blankestijn PJ.

Am Heart J. 2014 Mar;167(3):308-314.e3. doi: 10.1016/j.ahj.2013.11.010. Epub 2013 Dec 4.

PMID:
24576513
16.
17.

Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: a four-week, randomized, double-blinded, placebo-controlled study.

Ng CG, Boks MP, Roes KC, Zainal NZ, Sulaiman AH, Tan SB, de Wit NJ.

Eur Neuropsychopharmacol. 2014 Apr;24(4):491-8. doi: 10.1016/j.euroneuro.2014.01.016. Epub 2014 Jan 20.

PMID:
24503279
18.

Propensity score balance measures in pharmacoepidemiology: a simulation study.

Ali MS, Groenwold RH, Pestman WR, Belitser SV, Roes KC, Hoes AW, de Boer A, Klungel OH.

Pharmacoepidemiol Drug Saf. 2014 Aug;23(8):802-11. doi: 10.1002/pds.3574. Epub 2014 Jan 29.

PMID:
24478163
19.

Level of evidence for promising subgroup findings in an overall non-significant trial.

Tanniou J, Tweel IV, Teerenstra S, Roes KC.

Stat Methods Med Res. 2014 Jan 20. [Epub ahead of print]

PMID:
24448444
20.

Estimation of between-trial variance in sequential meta-analyses: a simulation study.

Novianti PW, Roes KC, van der Tweel I.

Contemp Clin Trials. 2014 Jan;37(1):129-38. doi: 10.1016/j.cct.2013.11.012. Epub 2013 Dec 7.

PMID:
24321246
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk